Literature DB >> 19863190

Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder.

Teresa Coccini1, Alessandro Crevani, Giorgio Rossi, Francesca Assandri, Umberto Balottin, Roberta Di Nardo, Luigi Manzo.   

Abstract

Several lines of evidence support the role of monoaminergic and cholinergic dysregulation in attention deficit hyperactivity disorder (ADHD) and the concept that peripheral blood neurotransmission indices may represent valuable surrogate CNS markers. We determined platelet MAO-B activity (p-MAO-B) and lymphocyte muscarinic cholinergic receptor binding (l-MR) in 44 unmedicated ADHD children (aged 9.1 +/- 2.87 years) and in 26 age-matched controls for comparison. Lower levels of p-MAO-B (approximately 35%) and l-MR (approximately 55%) in ADHD were observed compared with controls. Differences were gender-dependent: p-MAO-B was reduced in males only (5.20 +/- 2.99 vs 8.46 +/- 5.1 nmol mg(-1) protein h(-1) in ADHD and controls, respectively) and l-MR in females only (ADHD vs control: 6.63 +/- 1.75 and 15.30 +/- 8.35 fmol 10(-6) cells). The clinical significance was corroborated by the correlation between these markers and severity of specific symptoms: lower p-MAO-B associated with increased inattention scores (Conners' teacher-rating scale); lower l-MR associated with increased score for oppositional-defiant disorder (ODD) (SNAP-IV); and trend towards correlation between increased inattention (SNAP-IV) and lower l-MR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19863190     DOI: 10.3109/13547500903144436

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  7 in total

1.  Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides.

Authors:  Maryse F Bouchard; David C Bellinger; Robert O Wright; Marc G Weisskopf
Journal:  Pediatrics       Date:  2010-05-17       Impact factor: 7.124

Review 2.  Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.

Authors:  Marco Bortolato; Jean C Shih
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

Review 3.  From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency.

Authors:  Marco Bortolato; Gabriele Floris; Jean C Shih
Journal:  J Neural Transm (Vienna)       Date:  2018-05-10       Impact factor: 3.575

4.  The EEG as an index of neuromodulator balance in memory and mental illness.

Authors:  Costa Vakalopoulos
Journal:  Front Neurosci       Date:  2014-04-08       Impact factor: 4.677

5.  The effect of deficient muscarinic signaling on commonly reported biochemical effects in schizophrenia and convergence with genetic susceptibility loci in explaining symptom dimensions of psychosis.

Authors:  Costa Vakalopoulos
Journal:  Front Pharmacol       Date:  2014-12-15       Impact factor: 5.810

6.  Mercury Vapour Long-Lasting Exposure: Lymphocyte Muscarinic Receptors as Neurochemical Markers of Accidental Intoxication.

Authors:  E Roda; A Giampreti; S Vecchio; P Apostoli; T Coccini
Journal:  Case Rep Med       Date:  2016-10-31

7.  Decreased binding capacity (Bmax) of muscarinic acetylcholine receptors in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD).

Authors:  Jessica Johansson; Magnus Landgren; Elisabeth Fernell; Tommy Lewander; Nikolaos Venizelos
Journal:  Atten Defic Hyperact Disord       Date:  2013-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.